2m 2m 2m 2m 2m 2m 2m
KIORA PHARMA (KPRX)
NASDAQ
$2.56-$0.02 (-0.97%)
Price as of Oct 02, 2026 4:10 PM EDT- $11.4MMarket Cap
- -8.19%1-Year Change
- BiotechnologyIndustry
KIORA PHARMA (KPRX)
$2.56-$0.02 (-0.97%)
KPRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.58 | ||
Change | +$0.02 (+0.78%) | ||
Open | $2.57 | ||
High | $2.58 | ||
Low | $2.56 | ||
Previous Close | $2.56 | ||
Volume | 16,774 | ||
30-Day Average Volume | 13,604 | ||
1-Week Change | -3.37% | ||
1-Month Change | 2.79% | ||
1-Year Change | -8.19% | ||
3-Year Change | -49.50% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 4.4M | ||
Total Assets | $23.8M | ||
Market Cap | $11.4M | ||
Enterprise Value | $4.3M | ||
Period: QTR TTM FY | |||
Revenue | $16.0M | ||
Net Income | -$2.1M | ||
Free Cash Flow | -$1.9M | ||
EBIT | -$2.1M | ||
EBITDA | -$2.1M | ||
Net Working Capital | $18.9M | ||
EPS | -$0.34 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 0 | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 9 | ||
Last Split Date | 06/11/2024 | ||
Earnings & Revenue